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Gábor Czirják1, Mária Dux*2 and Peter Enyedi*1
Abstract
Background: TWIK-related spinal cord potassium channel (TRESK) background potassium channels have a key role in
controlling resting membrane potential and excitability of sensory neurons. A frameshift mutation leading to complete
loss of TRESK function has been identified in members of a family suffering from migraine with aura. In the present study,
we examined the role of TRESK channels on nociceptor function in mice.
Methods: Calcium imaging was used to investigate the role of TRESK channels in the modulation of the response
evoked by transient receptor potential vanilloid 1 (TRPV1) receptor stimulation in dorsal root ganglion neurons. Release
of calcitonin gene-related peptide from trigeminal afferents and changes in meningeal blood flow were also measured.
Experiments were performed on wild-type and TRESK knockout animals.
Results: Inhibition of TRESK increased the TRPV1-mediated calcium signal in dorsal root ganglion neurons and poten-
tiated capsaicin-induced increases in calcitonin gene-related peptide release and meningeal blood flow. Activation of
TRESK decreased the capsaicin sensitivity of sensory neurons, leading to an attenuation of capsaicin-induced increase in
meningeal blood flow. In TRESK knockout animals, TRPV1-mediated nociceptive reactions were unaffected by pretreat-
ment with TRESK modulators.
Conclusions: Pharmacological manipulation of TRESK channels influences the TRPV1-mediated functions of nocicep-
tors. Altered TRESK function might contribute to trigeminal nociceptor sensitization in migraine patients.
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Introduction
The primary headache migraine is a complex neuro-
vascular disorder, and its pathophysiology is not
completely understood. The neuropeptide calcitonin
gene-related peptide (CGRP) is a focus of migraine
research, since inhibiting CGRP release or blocking
CGRP receptors with antagonists or antibodies has
therapeutic effects in different forms of migraine
(1,2). CGRP is expressed in 40–50% of neurons in
human and rodent trigeminal ganglia (3,4).
Furthermore, the proportion of CGRP-containing tri-
geminal neurons innervating intracranial blood vessels
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seems to be higher than that supplying extracranial
structures (5).
A significant population of meningeal peptidergic
sensory neurons corresponds to chemosensitive noci-
ceptors, which express different members of the tran-
sient receptor potential (TRP) receptor family; for
example, transient receptor potential vanilloid 1
(TRPV1) or transient receptor potential ankyrin 1
(TRPA1) cation channels (6,7). Agonists of TRP recep-
tors (e.g. inhaled irritants) activating trigeminal noci-
ceptors may trigger headache attacks (8). Upon
stimulation, CGRP can be released from both the cen-
tral and peripheral terminals of primary sensory neu-
rons. CGRP released from the central terminals
contributes to the activation of second order brainstem
neurons of the nociceptive pathway, while CGRP
released by the peripheral terminals of meningeal affer-
ents dilates blood vessels and increases meningeal
blood flow (9,10).
Trigeminal nociceptors innervating the meningeal
tissues are considered to play a significant role in
both peripheral and central sensitization of the trigem-
inal nociceptive pathway, leading to increased head-
ache susceptibility in migraineurs (11).
Pathophysiological conditions enhancing produc-
tion of inflammatory mediators, oxidative or nitrosa-
tive stress may lead to sensitization of TRP channels by
increasing the number of functional membrane recep-
tors or modifying the structure of the channel protein,
leading to an increased probability of channel opening
(12–14). Sensitization of TRP channels may increase
the amount of CGRP released by the peripheral and
central terminals of the activated trigeminal neurons
leading to enhanced nociceptive reactions.
TWIK-related spinal cord potassium channel
(TRESK) is a member of the two pore domain (K2P)
potassium channel family. TRESK is activated by
increases in the cytoplasmic calcium signal, via dephos-
phorylation by the calcium/calmodulin-dependent
phosphatase calcineurin (15). The channel is highly
expressed in dorsal root and trigeminal ganglion neu-
rons and is a major determinant of the resting mem-
brane potential and excitability of these neurons
(16,17). In 2010, TRESK was reported to contribute
to the pathogenesis of typical migraine with aura. A
frameshift mutation leading to the complete loss of
TRESK function was identified in members of a
family suffering from migraine with aura, while the
mutation was absent in the individuals not affected
by migraine (18).
The present experiments were designed to reveal the
effect of TRESK potassium channels on the TRPV1-
mediated nociceptor functions, by applying the recently
described selective TRESK activator, cloxyquin
(19,20), and TRESK inhibitor, A2764 (21), in
wild-type and TRESK-deficient mice. We measured
calcium signals induced by the TRPV1 receptor agonist
capsaicin in dorsal root ganglion neurons isolated from
these animals, in order to estimate the significance of
TRESK potassium channels in trigeminal nociceptor
sensitization. The capsaicin-induced release of CGRP
from meningeal afferents and consequent changes in
meningeal blood flow were also compared in wild-
type and TRESK KO mice.
Methods
Animals
Wild-type FVB/Ant mice were obtained from the
Institute of Experimental Medicine of the Hungarian
Academy of Sciences (Budapest, Hungary). The gener-
ation and characterization of the TRESK KO mouse
line has been described previously (21). Adult mice
(both male and female) 3–6 months in age were used
for the experiments. The animals were maintained on a
12 hour light/dark cycle with free access to standard
laboratory chow and water in a specific pathogen-free
animal facility. All experimental procedures were con-
ducted in accordance with the Guide for the Care and
Use of Laboratory Animals as adopted by the NIH,
local state laws and institutional regulations.
Experiments were approved by the Animal Care and
Ethics Committee of Semmelweis University and the
University of Szeged (approval ID: XIV-I-001/2154-4/
2012 and XIV/2435/2020, respectively).
Calcium imaging
Wild-type or TRESK KO mice were killed by CO2
exposure. Dorsal root ganglia (DRG) were dissected
from the thoracic and lumbar levels of the spinal
cord and collected in sterile phosphate buffered saline
(PBS) containing (inmM): 137 NaCl, 2.7 KCl and 10
NaH2PO4, pH 7.4 at 4
C. Ganglia were incubated in
PBS containing 2 mg/ml collagenase enzyme (type I;
Worthingthon, USA) for 30minutes with gentle shak-
ing at 37C (for further details regarding the isolation
and culturing of the cells, see (22)). Cells were plated on
Ibidi 8-well m-slides (Ibidi GmbH, Germany) pretreated
with poly-L-lysine (Sigma-Aldrich, Germany). Calcium
imaging experiments were performed the day after iso-
lation of the neurons. Cells were loaded with Fura2-
AM (2 mM dissolved in recording solution, Molecular
Probes, USA) for 45min.
For experiments in which the effect of cloxyquin was
examined, the loading solution also contained the cal-
cineurin inhibitor cyclosporin A (1 mM, Sigma-Aldrich,
Germany). The composition of the recording solution
was the following (inmM): 140 NaCl, 3.6 KCl, 0.5
828 Cephalalgia 41(7)
MgCl2, 2 CaCl2, 11 glucose and 10 HEPES, pH 7.4.
After loading, cells were incubated in recording solu-
tion containing a TRESK channel modulator
(Cloxyquin, 30 mM, Sigma-Aldrich, or A2764 30 mM)
or vehicle control (6.5mM ethanol). The synthesis
and chemical characterization of A2764 has been
described previously (21). Images were acquired using
an inverted microscope (Axio Observer D1, Zeiss,
Germany) equipped with a 40 1.4 oil immersion
objective (Fluar, Zeiss, Germany) and a Cascade II
camera (Photometrics, USA). Excitation wavelengths
were set to 340 and 380 nm by a random-access mono-
chromator connected to a xenon arc lamp (DeltaRAM,
Photon Technology International, UK). Images were
acquired every 5 sec at an emission wavelength of 510
nm with MetaFluor software (Molecular Devices,
USA). The acquired images were analysed using
MetaFluor Offline software. Cells were challenged
with increasing concentrations of capsaicin (from 2 to
200 nM, Sigma-Aldrich, Germany). At the end of the
experiment, cells were depolarized with 60mM KCl
and cells not responding to this stimulus with a calcium
signal were excluded from the analysis. Data presented
were normalized to the F340/F380 ratio measured
before the application of capsaicin. Cells that
responded to capsaicin with an at least 10% increase
in F340/F380 signal compared to the control value
were considered to be sensitive to capsaicin. Data
shown in the paper are derived from two animals for
each examined condition (cell isolations were per-
formed independently on different days).
Ex vivo measurement of CGRP release
We used an established ex vivo dura mater preparation
to measure basal and stimulated CGRP release from
meningeal afferents (23). Wild-type and TRESK KO
mice were decapitated following cervical dislocation.
Skin and muscles were removed and the skull was
divided into halves along the midline. The cerebral
hemispheres were removed and the skull halves were
washed at room temperature for 30min in synthetic
interstitial fluid (SIF) containing (inmM): 135 NaCl,
5 KCl, 1 MgCl2, 5 CaCl2, 10 glucose and 10 HEPES,
pH 7.4. Skull halves were placed in a humid chamber
and the cranial fossae were filled with 60 ml SIF. For
CGRP measurement, three samples of the superfusate
were collected with a micropipette at periods of 5min.
The two skull halves of an animal were processed in
parallel according to the following protocol. From one
of the skull halves the first sample was taken after incu-
bating with SIF in order to determine basal CGRP
release. Then a TRESK antagonist A2764 (30 mM)
was applied for 5min followed by a third sample
obtained in the combined presence of A2764 and
capsaicin (6 nM). From the other skull half, the first
sample was taken under the same conditions as from
the first skull half, while, the second and third samples
were taken in the presence of the vehicle for A2764
(6.5mM ethanol in SIF). The flowchart of the experi-
ments is demonstrated in Figure 3(a). Sample amounts
of 50 ml diluted with 75 ml enzyme-linked immunoassay
(EIA) buffer were placed into Eppendorf cups and
immediately frozen at 70C for subsequent analysis.
For measurement of the CGRP concentration of sam-
ples, the EIA method was used (Bertin Pharma,
France). The CGRP concentrations of the superfusates
were measured in pg/ml. Changes induced in CGRP
release by capsaicin were expressed as percentage
changes relative to the basal release. The starting time
of the experiments was the same on each experimental
day. During the experiment, animals belonging to dif-
ferent genotypes were used in an alternating manner.
The researchers performing the CGRP concentration
determination were blinded to the genotype of the
animals.
In vivo recordings of meningeal blood flow
Changes in meningeal blood flow were measured in a
modified open cranial window preparation developed
originally for rats (24). Wild-type and TRESK KO
mice were anesthetized with intraperitoneal thiopental
sodium (80 mg/kg, Braun, Spain). The body tempera-
ture of the animals was kept at 37–37.5C with a heat-
ing pad. Mice were breathing spontaneously
throughout the experiment. The head of the animal
was fixed in a stereotaxic frame and the skin overlying
the skull was opened. A cranial window was drilled
into the parietal bone to expose the dura mater. To
prevent thermal damage of the underlying dura
mater, the parietal bone was cooled with saline.
Blood flow was recorded over a branch of the exposed
middle meningeal artery with a needle-type probe of a
laser Doppler flowmeter (Perimed, Sweden). To avoid
drying out of the dura mater, it was covered with SIF.
Stimulation of the dura mater was performed by topi-
cal application of capsaicin (1 or 6 nM) to the exposed
dura mater at a volume of 40 ml for 5min. Changes in
meningeal blood flow induced by capsaicin were mea-
sured before and after the preapplication of the
TRESK inhibitor A2764 (30 mM) or the TRESK acti-
vator cloxyquin (30 mM) for 5min. Meningeal blood
flow was measured in perfusion units (PU); data on
perfusion were processed with the Perisoft program
(Perimed, Sweden). Basal blood flow was determined
as the mean flow during a 3-min period prior to the
stimulation of the dura mater. Percentage changes in
meningeal blood flow in response to capsaicin was
determined as mean flow values within the 5min
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application relative to the basal flow. During the in vivo
blood flow measurements, the researcher performing
the experimental protocol was aware of the genotype
while during the data analysis blinding was achieved by
assigning codes to recording that did not reveal the
genotype of the animal.
Statistics
All values were expressed as mean values standard
error of the mean (SEM). Statistical analysis of the
data was performed using Statistica 13 (StatSoft,
USA). The effect of TRESK modulators on the calci-
um responses evoked by capsaicin (data shown in
Figures 1 and 2) was examined using the v2 test.
Analysis of the CGRP release and meningeal blood
flow (data shown in Figures 3 and 4) was performed
using the Wilcoxon test. A probability level of p< 0.05
was regarded as statistically significant.
Results
Pharmacological manipulation of TRESK channels
modulates the sensitivity of sensory neurons to
capsaicin
The role of TRESK channel in regulating the neuronal
activity induced by TRPV1 activation was examined by
performing ratiometric calcium imaging on DRG neu-
rons isolated from wild-type and TRESK KO mice. In
the first set of experiments, the effect of TRESK inhi-
bition on TRPV1 receptor function was examined.
Neurons isolated from wild-type or TRESK KO ani-
mals were incubated with the TRESK inhibitor A2764
(30 mM) or vehicle control (6.5mM ethanol) and sub-
sequently challenged with increasing concentrations of
capsaicin (2, 6 and 20 nM). Representative calcium
imaging traces from cells incubated with A2764 or
vehicle control are shown in Figure 1(a). The responses
to the different capsaicin concentrations are summa-
rized as a column graph in Figure 1(b) (control:
n¼ 114; A2764: n¼ 98 neurons) and also as scatter
plots (Supplementary Figure 1(a)–(c): 2, 6 and 20 nM,
respectively). Incubation with A2764 significantly
increased the ratio of neurons responding to 6 and
20 nM capsaicin compared to vehicle control
(p¼ 0.002 and p< 0.001, respectively). In the case of
2 nM capsaicin, there was a similar tendency; however,
it did not reach the level of statistical significance
(p¼ 0.11).
The effect of A2764 on the capsaicin responses of
TRESK KO DRG neurons was determined using the
same strategy as in the case of the wild-type neurons
(for representative recordings, see Figure 1(c)). The
responses to the different capsaicin concentrations are
summarized as a column graph in Figure 1(d) (control:
n¼ 155; A2764: n¼ 176 neurons) and also as scatter
plots (Supplementary Figure 1(a)–(c): 2, 6 and 20 nM,
respectively). Incubation with A2764 did not signifi-
cantly influence the ratio of capsaicin-responding cells
(p¼ 0.26, p¼ 0.48 and p¼ 0.27 for 2, 6 and 20 nM cap-
saicin concentrations, respectively).
In the next set of experiments, the consequence of
TRESK activation on the capsaicin-induced calcium
responses of DRG neurons was determined using the
TRESK activator cloxyquin. To maintain TRESK
channels in their basal (phosphorylated) state, neurons
were pretreated with the calcineurin inhibitor cyclo-
sporin A (1 mM) during the loading period.
Afterwards, neurons were incubated with cloxyquin
(30 mM) or vehicle control (6.5mM ethanol) and sub-
sequently challenged with increasing concentrations of
capsaicin (6, 20, 60 and 200 nM). Representative calci-
um imaging traces from wild-type neurons can be seen
in Figure 2(a). The responses to the different capsaicin
concentrations are summarized as a column graph in
Figure 2(b) (control: n¼ 130, cloxyquin: n¼ 110 neu-
rons) and also as scatter plots (Supplementary Figure 2
(a)–(d): 6, 20, 60 and 200 nM, respectively). Incubation
with cloxyquin significantly decreased the ratio of neu-
rons responding to capsaicin compared to vehicle con-
trol at all tested concentrations (p¼ 0.020, p¼ 0.006,
p¼ 0.028 and p¼ 0.003 for 6, 20, 60 and 200 nM cap-
saicin, respectively).
The effects of cloxyquin on the capsaicin sensitivity
of TRESK KO DRG neurons was also determined (for
representative recordings, see Figure 2(c)). Calcium
responses to the different capsaicin concentrations are
summarized as a column graph in Figure 2(d) (control:
n¼ 127; cloxyquin: n¼ 152 neurons) and also as scatter
plots (Supplementary Figure 2(a)–(d): 6, 20, 60 and
200 nM, respectively). In the TRESK-deficient DRG
neurons, incubation with cloxyquin did not influence
the ratio of capsaicin-responding cells (p¼ 0.100,
p¼ 0.065, p¼ 0.43 and p¼ 0.30 for 6, 20, 60 and
200 nM capsaicin, respectively).
Inhibition of TRESK channels potentiates capsaicin-
induced CGRP release
Basal release of CGRP in the ex vivo dura mater prep-
aration of wild-type mice was 27.8 4.7 pg/ml (n¼ 15)
and 29 4.6 pg/ml (n¼ 18) in TRESK KO mice.
Application of A2764 (30 mM) or vehicle control
(6.5mM ethanol) had no effect on CGRP release (com-
pare the columns labeled vehicle or A2764 to their
respective controls in Figures 3(b) and 3(c)). After the
solvent or A2764 pretreatment, capsaicin (6 nM) was
applied to the dura mater preparation to stimulate
CGRP release (see the columns labeled capsaicin in
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Figures 3(b) and 3(c)). To determine the effect of
A2764 on the capsaicin-evoked CGRP release, the
CGRP concentrations measured after capsaicin stimu-
lation were normalized to their respective basal values.
In wild-type animals, when the dura mater was pre-
treated with vehicle, application of capsaicin increased
the CGRP release by 7.3 8.2% (n¼ 15). However,
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Figure 1. Effect of the TRESK inhibitor A2764 on the calcium signal of dorsal root ganglion neurons evoked by capsaicin. Dorsal root
ganglion neurons loaded with 2 mM Fura2-AM were preincubated in control solution (containing ethanol, 6.5mM) or A2764 (30 mM).
Cells were stimulated with increasing concentrations (2, 6 and 20 nM) of capsaicin. As a positive control, at the end of the experiment,
cells were depolarized by application of 60mM KCl, unresponsive cells were excluded from the analysis. Data were normalized to the
control value measured before application of capsaicin. (a) Representative calcium imaging traces of wild-type (WT) dorsal root
ganglion neurons from a single microscopic field are shown; left panel: Control cells (n¼ 16), right panel: Cells pretreated with A2764
(n¼ 17). Application of consecutively increasing capsaicin concentrations and the 60mM KCl test stimulus are marked with horizontal
bars above the graphs. (b) The percentage of wild-type neurons responding to different concentrations of capsaicin are shown as a
column graph (cells that responded to capsaicin with an at least 10% increase in F340/F380 signal compared to the control value were
considered to be sensitive to capsaicin). Significant differences between the A2764 (red columns) and vehicle-treated groups (black
columns) are marked with asterisks (*). (c) Representative calcium imaging traces of TRESK KO dorsal root ganglion neurons from a
single microscopic field are shown; left panel: Control cells (n¼ 19), right panel: Cells pretreated with A2764 (n¼ 16). Application of
consecutively increasing capsaicin concentrations and the 60mM KCl test stimulus are marked with horizontal bars above the graphs.
(d) The percentage of TRESK KO neurons responding to different concentrations of capsaicin are shown as a column graph (cells that
responded to capsaicin with an at least 10% increase in F340/F380 signal compared to the control value were considered to be
sensitive to capsaicin).
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capsaicin increased CGRP release by 41.0 13.4%
(n¼ 15). This increase in capsaicin-induced CGRP
release was significantly higher (p¼ 0.004) than the
capsaicin-induced CGRP release of the
vehicle-pretreated control (for a summary, see the
right panel in Figure 3(b)). In TRESK KO animals,
the increase in capsaicin-induced CGRP release after
vehicle treatment was 2.9 7.4% (n¼ 18) and 12.2
Vehicle
Capsaicin (nM)
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Figure 2. Effect of the TRESK activator cloxyquin on the calcium signal of dorsal root ganglion neurons evoked by capsaicin. Dorsal
root ganglion neurons loaded with 2 mM Fura2-AM were preincubated in control solution (containing ethanol, 6.5mM) or cloxyquin
(30 mM). Cells were stimulated with increasing concentrations (6, 20, 60 and 200 nM) of capsaicin. As a positive control, at the end of
the experiment, cells were depolarized by application of 60mM KCl, unresponsive cells were excluded from the analysis. Data were
normalized to the control value measured before application of capsaicin. (a) Representative calcium imaging traces of wild-type (WT)
dorsal root ganglion neurons from a single microscopic field are shown; left panel: Control cells (n¼ 20), right panel: Cells pretreated
with cloxyquin (n¼ 13). Application of consecutively increasing capsaicin concentrations and the 60mM KCl test stimulus are marked
with horizontal bars above the graphs. (b) The percentage of wild-type neurons responding to different concentrations of capsaicin
are shown as a column graph (cells that responded to capsaicin with an at least 10% increase in F340/F380 signal compared to the
control value were considered to be sensitive to capsaicin). Significant differences between the cloxyquin (red columns) and vehicle
treated groups (black columns) are marked with asterisks (*). (c) Representative calcium imaging traces of TRESK KO dorsal root
ganglion neurons from a single microscopic field are shown; left panel: Control cells (n¼ 19), right panel: Cells pretreated with
cloxyquin (n¼ 12). Application of consecutively increasing capsaicin concentrations and the 60mM KCl test stimulus are marked with
horizontal bars above. the graphs. (d) The percentage of TRESK KO neurons responding to different concentrations of capsaicin are
shown as a column graph (cells that responded to capsaicin with an at least 10% increase in F340/F380 signal compared to the control
value were considered to be sensitive to capsaicin).
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9.9% after pretreatment with A2764 (for a summary,
see the right panel in Figure 3(c)). The difference
between the capsaicin-induced CGRP release of the
vehicle and A2764 pretreated groups was not signifi-
cant (p¼ 0.23).
Functional condition of TRESK channels modifies
TRPV1-mediated changes in meningeal blood flow
Basal meningeal blood flow in wild-type and TRESK




















































































































































































Figure 3. Inhibition of TRESK channels enhances capsaicin-induced CGRP release from trigeminal afferents. Hemisected mouse skull
preparation with the adhering dura mater was incubated ex vivo and the CGRP release into the incubation medium was measured
during three consecutive 5 min periods. (a) The experimental protocol is summarized as a flowchart. The 30 min preincubation was
followed by a 5 min control period (basal release), thereafter solvent or A2764 (30 mM) was applied for 5 min; finally, the preparation
was stimulated by capsaicin (6 nM). (b) The CGRP release of wild-type (WT) mouse skulls (n¼ 15 animals) are summarized as box
plots; left: Vehicle pretreatment, middle: A2764 pretreatment, right: Normalized values of the third, capsaicin challenge period. The
difference in the capsaicin-evoked CGRP release between the vehicle and A2764 treated groups was statistically significant. (c) The
CGRP release of TRESK KO mouse skulls (n¼ 18 animals) are summarized as box plots; left: Vehicle pretreatment, middle: A2764
pretreatment, right: Normalized values of the third, capsaicin challenge period. The difference in the capsaicin-evoked CGRP release
between the vehicle and A2764 treated groups was not significant.
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was in the same range, varying between 90–250 perfu-
sion units (PU). Application of capsaicin (1 nM) failed
to induce significant changes in meningeal blood flow
(n¼ 11 and n¼ 9 measuring probes for wild-type and
TRESK KO animals, respectively, see the columns
labeled 1 nM capsaicin in Figure 4(a)). We measured
a slight but not significant decrease in perfusion in both
groups of animals. Meningeal blood flow was reduced
to 97.3 1.6% (p¼ 0.13) and 94.7 2.6% (p¼ 0.08) of
baseline in wild-type and TRESK KO animals, respec-
tively. Pretreatment with A2764 (30 mM) did not signif-
icantly influence the meningeal blood flow. In TRESK
KO animals, pretreatment with A2764 failed to change
the slight vasoconstrictor effect of capsaicin; it reduced
meningeal blood flow to 95.3 1.3% (p¼ 0.47) of the
baseline, as seen in Figure 4(a). In wild-type animals
application of capsaicin (1 nM) following pretreatment
of the dura mater with A2764 increased meningeal
blood flow to 104 0.8% of the baseline (Figure 4
(a)). The capsaicin-induced increase in meningeal
blood flow after A2764 pretreatment was significantly
different from the effect of capsaicin without A2764
pretreatment (p< 0.001).
To test the effect of TRESK channel activation on
capsaicin-induced blood flow changes we used a
higher capsaicin concentration (6 nM). Application of
6 nM capsaicin increased meningeal blood flow in both
wild-type (104.5 0.8%, n¼ 7, p¼ 0.001) and TRESK
KO animals (103.9 1.1%, n¼ 12, p¼ 0.005), as seen
in Figure 4(b). Application of cloxyquin (30 mM) had
no significant effect on meningeal blood flow. In
TRESK KO mice, capsaicin increased blood flow to
101.8 1.1% of the control value after the pretreat-
ment with cloxyquin. This change was not significantly
different from the effect of capsaicin without cloxyquin
preapplication (p¼ 0.072).
However, in wild-type mice, when the dura mater
was stimulated with capsaicin after pretreatment with
cloxyquin, the meningeal blood flow was reduced to
98.5 2.4% of baseline (Figure 4(b)). This reduction
in the effect of capsaicin was statistically significant
(p¼ 0.036).
Discussion
The present study was initiated in an attempt to reveal
possible functional cooperation between TRESK back-
ground potassium channels and TRPV1 receptors
expressed by nociceptors. Therefore wild-type and
TRESK KO mice were studied by applying well estab-
lished methods of experimental pain and headache
research.
The non-selective cation channel TRPV1 is
expressed by small-diameter dorsal root and trigeminal
ganglion neurons with nociceptor function (25,26).
TRPV1 is an integrator of nociceptive stimuli; it can
be activated by various exogenous and endogenous
physical and chemical stimuli and it is also a target
for pathophysiological processes leading to structural
changes and consequent sensitization of the receptor
(26). These features make the TRPV1 receptor an
ideal contributor to peripheral and central sensitization
of the nociceptive pathway. Although only 30–50% of
primary sensory neurons express the vasodilator pep-
tide CGRP (3,27), sensory neurogenic vasodilatation
induced by CGRP release is regarded as a reliable indi-
cator of the nociceptor activation. The beneficial effect
of various anti-migraine drugs related to their CGRP
release inhibiting effect or to the inhibition of the
CGRP action supports the important role of this pep-
tide in the trigeminal system and the pathophysiology
of headaches (11).
The K2P channel TRESK is a major component of
the background potassium current in the primary sen-
sory neurons of the dorsal root and trigeminal ganglia.
Accordingly, an increased sensitivity to various painful
stimuli have been described in TRESK KO animals in
different regions of the body (28–32) and reduced
abundance of TRESK was associated with pathologi-
cal pain conditions (33,34). A recent report suggested
that trigeminal neurons are particularly sensitive to
altered TRESK activity (29). On the other hand, phar-
macological activation (30) or overexpression (33,34)
of the channel can reduce cellular excitability and pre-
vent the development of increased sensitivity to differ-
ent stimuli.
These results, in combination with the sensory
neuron-specific expression of the channel (35–39)
make TRESK an attractive drug target for the allevia-
tion of pain in the disorders of nociception. TRESK
was implicated in the pathophysiology of migraine
when a dominant negative mutation of TRESK
(F139WfsX24) was identified in a family, members of
which suffer from migraine with aura (18). Since this
first report, further dominant negative mutations of
TRESK (W101R, C110R) have been identified in
human genetic studies (40–42).
Single-cell RNA sequencing studies performed on
mouse somatosensory neurons have shown that
TRESK is present in cells also expressing the TRPV1
receptor and CGRP (37,38). Nociceptors of dorsal root
and trigeminal ganglia share a lot of similarities regard-
ing their receptors and peptide content (43,44). Hence,
data obtained in dorsal root ganglion neurons may well
also be applicable for trigeminal nociceptors.
Although the TRPV1 channel was originally consid-
ered as a cation channel with no voltage sensitivity,
patch-clamp studies revealed that temperature sensing
is linked to voltage-dependent changes in TRPV1.










































































































































































































Figure 4. TRESK channel activity modulates TRPV1-induced changes in meningeal blood flow. Changes in meningeal blood flow
induced by capsaicin application (1 or 6 nM) were measured in wild-type (WT) and TRESK KO mice before and after pretreating the
dura mater with A2764 (30 mM) (a) or cloxyquin (30 mM) (b). Significant differences in the effect of capsaicin before and after
pretreatment are marked with asterisks (*). (a) In wild-type mice (left), application of A2764 to the dura mater was able to significantly
potentiate the effect of 1 nM capsaicin on meningeal blood flow (n¼ 11 probe positions from n¼ 6 animals). In TRESK KO mice
(right), application of 30 mM A2764 did not influence the effect of capsaicin on the meningeal blood flow (n¼ 9 probe positions from
n¼ 5 animals). (b) In wild-type mice (left), application of 30 mM cloxyquin to the dura mater significantly decreased the effect of 6 nM
capsaicin on meningeal blood flow (n¼ 11 probe positions from n¼ 5 animals). In TRESK KO mice (right), application of cloxyquin did
not influence the effect of capsaicin on the meningeal blood flow (n¼ 12 probe positions from n¼ 8 animals).
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membrane depolarization. As alterations in the mem-
brane potential influence, the signaling of TRPV1 (45–
47), we wanted to test whether pharmacological manip-
ulation of TRESK may influence the sensitivity of sen-
sory neurons to capsaicin and regulate TRPV1-
mediated nociceptor functions.
The sensitivity of DRG neurons from wild-type and
TRESK KO animals to a potent TRPV1 agonist, cap-
saicin, was determined by using cytoplasmic calcium
imaging. There was no difference in the capsaicin sen-
sitivity of wild-type and TRESK KO neurons, which is
in good agreement with a recent study comparing the
responses of wild-type and TRESK KO DRG neurons
to various TRP channel agonists (32).
However, when wild-type DRG neurons were pre-
treated with drugs modulating TRESK activity, the
ratio of cells responding to submaximal capsaicin chal-
lenges significantly increased (in case of the TRESK
inhibitor, A2764) or decreased (in case of the TRESK
activator, cloxyquin). In DRGs of TRESK KO ani-
mals, incubation with A2764 or cloxyquin did not
influence the ratio of capsaicin-responding cells, indi-
cating that the changes seen in wild-type neurons were
consequences of the modified TRESK activity.
Accordingly, selective pharmacological manipulation
of TRESK can regulate the sensitivity to submaximal
concentrations of capsaicin in sensory neurons.
Stimulation of TRPV1 receptors releases the
potent vasodilator peptide CGRP from nociceptors
(6,48). In agreement with our calcium imaging data,
in the ex vivo dura mater preparation, inhibition of
TRESK by A2764 significantly increased the amount
of CGRP released by capsaicin. Application of
A2764 had no effect on the CGRP release in
TRESK KO animals. Cloxyquin pretreatment failed
to affect the capsaicin evoked CGRP release (data
not shown). A possible explanation for the lack of
effect is that cloxyquin does not stimulate TRESK
further if it has been activated via the natural/phys-
iological mechanism (19). During the processing of
the dura preparation, a central axotomy of the tri-
geminal neurons is unavoidable and the consequent
calcium signal (and dephosphorylation of TRESK by
calcineurin) may well lead to long-lasting activation
of the channel (15). Since we could not guarantee the
basal, phosphorylated state of TRESK channels in
this experimental model, which would have been nec-
essary for the efficient activation by cloxyquin in the
ex vivo preparation, we did not pursue these experi-
ments further.
Release of CGRP from meningeal afferents and the
consequent vasodilatation are important components
of migraine pathophysiology (10,49). In agreement
with the results of our calcium imaging and CGRP
release experiments, inhibition of TRESK potentiated
the blood flow increasing effect of capsaicin.
In these experiments, we used a low capsaicin con-
centration (1 nM) that failed to increase meningeal
blood flow in wild-type animals. Capsaicin application
has a dual function in the trigeminovascular system.
Vasodilatation induced by sensory CGRP release and
vasoconstriction reducing blood flow are parallel reac-
tions observed in the trigeminovascular system upon
capsaicin application (6). Vasoconstriction is the
result of direct stimulation of vascular TRPV1 recep-
tors leading to Ca2þ inflow and contraction of the vas-
cular smooth muscle cells (50). In wild-type mice the
slightly stronger direct vasoconstrictor effect of capsa-
icin was turned into a blood flow increasing effect after
blocking the TRESK channels.
In our experiments testing the effect of TRESK
channel activation by cloxyquin on TRPV1 function,
we applied a higher capsaicin concentration (6 nM).
Increases in meningeal blood flow measured in wild-
type animals indicate a higher CGRP release that over-
rides the direct vasoconstrictor effect of capsaicin.
Pretreatment of the dura mater with cloxyquin reduced
the amount of CGRP released by stimulation with cap-
saicin, attenuating increases in meningeal blood flow in
wild-type animals. In TRESK KO animals, modulators
of the TRESK channel failed to affect TRPV1- mediat-
ed changes in meningeal blood flow, indicating that the
hemodynamic changes seen in wild-type animals were
the consequences of the modified TRESK activity.
Although the role of TRESK in the pathogenesis of
migraine remains controversial, recent studies in KO
animals show that the genetic ablation of TRESK
leads to an increased sensitivity to painful stimuli in
animal models of migraine (29,30). In the present
experiments, specific modulators of TRESK channel
activity (both activator and inhibitor, cloxyquin and
A2764, respectively) were applied in multiple systems
(in vitro, ex vivo and in vivo) in wild-type animals. In
addition, a TRESK KO strain was used in order to
confirm the specificity of the applied drugs in all exper-
imental systems.
Our results indicate that altering the TRESK activ-
ity can modify the calcium signal generation of isolated
nociceptive neurons, inhibition of TRESK activity
increases the liberation of the vasoactive peptide
CGRP in a tissue preparation, and the activation or
inhibition of the channel also influences the meningeal
vascular response to a nociceptive stimulus, capsaicin.
In conclusion, our data show that pharmacological
modulation of TRESK activity can be used to manip-
ulate nociceptor sensitivity; thus, in the future, selective
and potent activators of TRESK may be considered as




• In primary sensory neurons, the functional condition of TRESK background potassium channels modifies
the calcium signal generation of sensory neurons in response to capsaicin.
• Inhibition of TRESK channels potentiates CGRP release from trigeminal afferents induced by the acti-
vation of TRPV1.
• Pharmacological modulation of TRESK channels modifies the TRPV1-mediated increases in meningeal
blood flow.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
The authors disclosed receipt of the following financial sup-
port for the research, authorship, and/or publication of this
article: This work was supported by research grants GINOP-
2.3.2-15-2016-00034, K119597 and K127988 projects of the
Hungarian National Research, Development and Innovation
Office (NKFIH) and the Higher Education Institutional
Excellence Program of the Ministry of Human Capacities in
Hungary, within the framework of the Molecular Biology
thematic program.
References
1. Deen M, Correnti E, Kamm K, et al. Blocking CGRP in
migraine patients – a review of pros and cons. J Headache
Pain 2017; 18: 96.
2. Edvinsson L, Haanes KA, Warfvinge K, et al. CGRP as
the target of new migraine therapies – successful transla-
tion from bench to clinic. Nat Rev Neurol 2018; 14:
338–350.
3. Lennerz JK, Ruhle V, Ceppa EP, et al. Calcitonin
receptor-like receptor (CLR), receptor activity-
modifying protein 1 (RAMP1), and calcitonin gene-
related peptide (CGRP) immunoreactivity in the rat tri-
geminovascular system: Differences between peripheral
and central CGRP receptor distribution. J Comp
Neurol 2008; 507: 1277–1299.
4. Eftekhari S, Salvatore CA, Calamari A, et al. Differential
distribution of calcitonin gene-related peptide and its
receptor components in the human trigeminal ganglion.
Neuroscience 2010; 169: 683–696.
5. O’Connor TP and van der Kooy D. Enrichment of a
vasoactive neuropeptide (calcitonin gene related peptide)
in the trigeminal sensory projection to the intracranial
arteries. J Neurosci 1988; 8: 2468–2476.
6. Dux M, Sántha P and Jancso G. Capsaicin-sensitive neu-
rogenic sensory vasodilatation in the dura mater of the
rat. J Physiol 2003; 552: 859–867.
7. Denner AC, Vogler B, Messlinger K, et al. Role of tran-
sient receptor potential ankyrin 1 receptors in rodent
models of meningeal nociception – experiments in vitro.
Eur J Pain 2017; 21: 843–854.
8. Edelmayer RM, Le LN, Yan J, et al. Activation of
TRPA1 on dural afferents: A potential mechanism of
headache pain. Pain 2012; 153: 1949–1958.
9. Edvinsson L. The trigeminovascular pathway: Role of
CGRP and CGRP receptors in migraine. Headache
2017; 57: 47–55.
10. Iyengar S, Johnson KW, Ossipov MH, et al. CGRP and
the trigeminal system in migraine. Headache 2019; 59:
659–681.
11. Russo AF. Calcitonin gene-related peptide (CGRP): A
new target for migraine. Annu Rev Pharmacol Toxicol
2015; 55: 533–552.
12. Mickle AD, Shepherd AJ and Mohapatra DP.
Nociceptive TRP channels: Sensory detectors and trans-
ducers in multiple pain pathologies. Pharmaceuticals
(Basel) 2016; 9: 72.
13. Marics B, Peitl B, Varga A, et al. Diet-induced obesity
alters dural CGRP release and potentiates TRPA1-
mediated trigeminovascular responses. Cephalalgia
2017; 37: 581–591.
14. Dux M, Rosta J and Messlinger K. TRP channels in the
focus of trigeminal nociceptor sensitization contributing
to primary headaches. Int J Mol Sci 2020; 21: 342.
15. Czirják G, Toth ZE and Enyedi P. The two-pore domain
Kþ channel, TRESK, is activated by the cytoplasmic
calcium signal through calcineurin. J Biol Chem 2004;
279: 18550–18558.
16. Kang D and Kim D. TREK-2 (K2P10.1) and TRESK
(K2P18.1) are major background Kþ channels in dorsal
root ganglion neurons. Am J Physiol Cell Physiol 2006;
291: C138–C146.
17. Yoo S, Liu J, Sabbadini M, et al. Regional expression of
the anesthetic-activated potassium channel TRESK in
the rat nervous system. Neurosci Lett 2009; 465: 79–84.
18. Lafreniere RG, Cader MZ, Poulin JF, et al. A dominant-
negative mutation in the TRESK potassium channel is
linked to familial migraine with aura. Nat Med 2010; 16:
1157–1160.
19. Lengyel M, Dobolyi A, Czirják G, et al. Selective and
state-dependent activation of TRESK (K2P 18.1) back-
ground potassium channel by cloxyquin. Br J Pharmacol
2017; 174: 2102–2113.
20. Wright PD, Weir G, Cartland J, et al. Cloxyquin
(5-chloroquinolin-8-ol) is an activator of the two-pore
domain potassium channel TRESK. Biochem Biophys
Res Comm 2013; 441: 463–468.
21. Lengyel M, Erdelyi F, Pergel E, et al. Chemically modi-
fied derivatives of the activator compound cloxyquin
Lengyel et al. 837
exert inhibitory effect on TRESK (K2P18.1) background
potassium channel. Mol Pharmacol 2019; 95: 652–660.
22. Braun G, Lengyel M, Enyedi P, et al. Differential sensi-
tivity of TREK-1, TREK-2 and TRAAK background
potassium channels to the polycationic dye ruthenium
red. Brit J Pharmacol 2015; 172: 1728–1738.
23. Ebersberger A, Averbeck B, Messlinger K, et al. Release
of substance P, calcitonin gene-related peptide and pros-
taglandin E2 from rat dura mater encephali following
electrical and chemical stimulation in vitro.
Neuroscience 1999; 89: 901–907.
24. Kurosawa M, Messlinger K, Pawlak M, et al. Increase of
meningeal blood flow after electrical stimulation of rat
dura mater encephali: Mediation by calcitonin gene-
related peptide. Br J Pharmacol 1995; 114: 1397–1402.
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